PAX6 and Hyperglycemia: In other words, the results suggest that our PAX6 gene delivery approach enhances islet potency, provides long‐term graft preservation, and enables the reduction of the mass of islets required to reverse hyperglycemia in each transplantation, which therefore potentially enables more diabetic patients to receive islet transplantation.